Seminar Title:
Shikonin-mediated anticancer activity: Targeting mitochondria dysfunction, DNA damage and EMT to suppress oral cancer.
Seminar Type:
Departmental Seminar
Department:
Life Science
Speaker Name:
Ashish Kumar Khamari
Speaker Type:
Student
Venue:
LS Seminar Hall
Date and Time:
05 Nov 2026 04:30 PM
Contact:
7846960636
Abstract:
Phytotherapy has provided a new insight to the treatment of many cancers, including oral cancer, over conventional chemotherapeutic agents as it has lower side effects. Shikonin is a naturally biologically active naphthoquinone found in the roots of Lithospermum erythrorhizon plant exhibits strong cytotoxic effects against various cancers, including oral cancer. The present study assesses the anticancer effectiveness of Shikonin in SCC9 and H357 oral cancer cell lines, emphasising its antiproliferative, antimigratory, apoptosis-inducing mechanisms. We performed a series of assays, such as MTT, colony assay, wound healing, tumoroid assay, AO/EtBr, DAPI, comet assay, qRT-PCR, western blotting, and measurements of reactive oxygen species (ROS) and mitochondrial membrane potential (MMP). As a result, we found that Shikonin reduced the viability, proliferation, and tumorigenicity of SCC9 and H357 cells in a time and concentration-dependent manner. It promotes apoptosis via overexpressing proapoptotic Bax and caspase 3 via enhancing ROS that leads to MMP depletion. Moreover, Shikonin inhibited cell migration by regulating epithelial-mesenchymal transition (EMT) markers. In summary, our findings suggest that Shikonin possesses strong anticancer properties against oral cancer cells under both in vitro and ex vivo conditions, underscoring its promise as a potential therapeutic agent for treatment of oral cancer.

